BARCLAYS PLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$105,577
+3300.6%
0.00%
Q2 2022$0
-100.0%
164
-97.6%
0.00%
Q1 2022$22,000
-94.8%
6,694
-93.3%
0.00%
Q4 2021$420,000
+200.0%
100,102
+483.1%
0.00%
Q3 2021$140,000
+211.1%
17,166
+188.7%
0.00%
Q2 2021$45,000
-84.9%
5,945
-82.7%
0.00%
Q1 2021$299,000
+184.8%
34,344
+159.0%
0.00%
Q4 2020$105,000
-30.0%
13,260
-29.5%
0.00%
Q3 2020$150,000
-18.9%
18,800
-0.1%
0.00%
Q2 2020$185,000
+140.3%
18,810
+86.0%
0.00%
Q1 2020$77,000
-34.7%
10,112
-67.0%
0.00%
Q4 2019$118,000
+55.3%
30,621
+101.9%
0.00%
Q3 2019$76,000
-41.5%
15,168
-23.2%
0.00%
Q2 2019$130,000
-18.2%
19,740
-6.0%
0.00%
Q1 2019$159,000
+45.9%
21,005
+54.6%
0.00%
Q4 2018$109,000
-29.7%
13,590
+12.6%
0.00%
Q3 2018$155,000
+474.1%
12,073
+423.8%
0.00%
Q2 2018$27,000
-49.1%
2,305
-69.4%
0.00%
Q1 2018$53,000
-75.5%
7,522
-77.3%
0.00%
Q4 2017$216,00033,192
+1659500.0%
0.00%
Q2 2017$0
-100.0%
2
-99.9%
0.00%
Q1 2017$11,0002,557
+5014.0%
0.00%
Q4 2016$050
+1150.0%
0.00%
Q3 2016$040.0%0.00%
Q2 2016$0
-100.0%
4
-99.8%
0.00%
Q2 2015$14,0002,2680.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Skylands Capital, LLC 1,772,000$13,379,0001.58%
Sargent Investment Group, LLC 856,315$6,465,0001.53%
Avenir Corp 1,366,549$10,317,0000.82%
CM Management, LLC 150,000$1,133,0000.82%
Winning Points Advisors, LLC 136,900$1,035,0000.78%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,397,0000.46%
SECTORAL ASSET MANAGEMENT INC 244,660$1,847,0000.15%
Redmile Group, LLC 1,304,369$9,848,0000.15%
Granahan Investment Management 1,003,546$7,577,0000.14%
ACT CAPITAL MANAGEMENT, LLC 35,000$265,0000.14%
View complete list of CYTOSORBENTS CORP shareholders